NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Investigations of Dementia in Parkinson Disease
Investigations of Dementia in Parkinson Disease
RecruitingN/A
Sponsor: Washington University School of Medicine
Conditions: Parkinsons
Interventions: PiB and VAT
Countries: United States
The purpose of this study is to use a brain imaging method called Pittsburgh B (PIB) Positron Emission Tomography (PET) and Vesicular Cholinergic Transport (VAT) PET to determine dementia subtypes in patients with Parkinson disease (PD). The ultimate goal of this project is to be able to identify individuals with PD who are at risk of developing dementia, and to distinguish the underlying cause of dementia.
Eligibility overview
Sex: ALL
Age: 50 Years to —
Healthy volunteers: Yes
Study type: OBSERVATIONAL
Eligibility criteria
Inclusion Criteria: * PD patients must exhibit three of the following cardinal signs: rest tremor, rigidity, bradykinesia, or postural instability; or two of these features with one of the first three displaying asymmetry. Exclusion Criteria: * history of head trauma, major neurological or psychiatric diseases other than Parkinson disease and dementia, e.g. stroke, multiple sclerosis, depression or schizophrenia. * severe systemic diseases. * inability to lie still for 90 minutes. * metallic implants, pacemakers, or any other contraindication to MRI. * refusal to consent to brain donation.
Locations (1)
- St Louis, Missouri, United States